Neosem (253590) Company Analysis Report
One-line summary: "As the world's No. 1 maker of test equipment for high-performance storage devices (SSDs), which are essential in the AI era, Neosem has seized an exclusive opportunity as its competitor has exited the market."
What kind of company is Neosem?
- Semiconductor defect inspectors: It makes equipment that tests whether SSDs, the storage devices used in computers and servers, work properly.
- Global No. 1: After acquiring a U.S. competitor in 2015, it has held the No. 1 global market share in this field for more than 10 years.
- Revenue structure: About 80% of its revenue comes from this SSD test equipment (module testing).
Investment points
- ① AI is driving the switch to "faster SSDs" (Gen4 → Gen5/6) As AI technology advances, the amount of data to be processed has grown enormously.
So next-generation SSDs (Gen5, Gen6) that are much faster than existing SSDs have become necessary.
When new SSDs are made, new equipment to test them is also absolutely necessary. This is a big opportunity for Neosem.
- ② A powerful competitor has disappeared (an open field) Japan's giant competitor Advantest exited this business in January 2025.
As a result, Neosem has become the only player in the next-generation (Gen5) test market.
Customers now have no choice but to use Neosem's equipment.
- ③ Ready for future technologies (CXL, HBF) too
CXL: A technology that lets computer components exchange data faster. Neosem developed test equipment for this as a world first as well.
HBF: A new technology that supports HBM (high bandwidth memory), the core of AI semiconductors. It is still at an early stage, but Neosem is researching it with the aim of commercialization in 2026-2027.
Earnings and share price
Recent situation: In 2025, customers cut back somewhat on SSD investment as they poured money into HBM (a different type of memory). So earnings stalled for a while.
Outlook: From 2026, investment is expected to pick up again, and revenue is expected to grow significantly as markets for new technologies (CXL, etc.) open up.
Share price level: The current share price is fairly expensive relative to what the company earns (PER of 76x). However, investors are giving it a high score based on its future growth potential rather than its current earnings.
4. Points of caution (risks)
High valuation: The stock trades at a premium to its industry peers, so if growth is not as fast as expected, the share price could be shaken.
Pace of new technology adoption: The future technologies the company is preparing (HBF, etc.) may take longer than expected to establish themselves in the market.
In summary: Neosem is the leading stock in "high-performance storage device testing," a field that has become essential due to advances in AI. Its market dominance has grown stronger with its competitor's exit from the business, and it is well prepared with future growth technologies, making it a company with promising long-term growth.